Search

Your search keyword '"Pan, Jianji"' showing total 548 results

Search Constraints

Start Over You searched for: Author "Pan, Jianji" Remove constraint Author: "Pan, Jianji"
548 results on '"Pan, Jianji"'

Search Results

9. Principles and Clinical Applications of Boron Neutron Capture Therapy

12. Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309)

20. Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma

22. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

27. STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer

28. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

29. Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

31. Long-Term Outcome in Cervical Lymph Node-Positive Nasopharyngeal Carcinoma Following Intensity Modulated Radiation Therapy With One-Step Cervical Nodal Clinical Target Volume Delineation by Geometric-Anatomic Expansion From Nodal Gross Target Volume: A Double-Center Experience

32. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

35. STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer.

38. Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma

40. Additional file 6 of Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma

41. Additional file 7 of Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma

42. Additional file 8 of Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma

43. Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity‐modulated radiotherapy treatment of T4 nasopharyngeal carcinoma

Catalog

Books, media, physical & digital resources